Sanofi (LON:0O59)

Market Cap	85.31B
Revenue (ttm)	39.21B
Net Income (ttm)	7.82B
Shares Out	n/a
EPS (ttm)	6.30
PE Ratio	10.91
Forward PE	9.83
Dividend	3.30 (4.12%)
Ex-Dividend Date	May 12, 2025

Volume	938,661
Average Volume	479,193
Open	78.12
Previous Close	78.96
Day's Range	76.78 - 80.43
52-Week Range	76.78 - 110.84
Beta	0.40
RSI	37.91
Earnings Date	Jul 31, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O59

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR